Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 4 Lung Neoplasms 3 Ovarian Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Renal Insufficiency 1 Recurrence 1 Rectal Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1 Liver Diseases 1 Leiomyosarcoma 1 Gliosarcoma 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Central Nervous System Neoplasms 1 Breast Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

Cyclophosphamide 25 Temozolomide 22 Vincristine 18 Irinotecan 18 Doxorubicin 13 Topotecan 10 Melphalan 10 Etoposide 10 Ifosfamide 8 Busulfan 8 cabozantinib 7 Magnetic Resonance Spectroscopy 7 Granulocyte Colony-Stimulating Factor 7 Filgrastim 6 regorafenib 5 fludarabine 5 X-Rays 5 Specimen Handling 5 Sirolimus 5 Radiotherapy 5 Gemcitabine 5 Drug Therapy 5 pegfilgrastim 4 palbociclib 4 liposomal doxorubicin 4 irinotecan sucrosofate 4 ganitumab 4 fludarabine phosphate 4 Trabectedin 4 Phantoms, Imaging 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Ewing × rubitecan × Clear all

NCT00492141 2012-08-02

Aerosol L9-NC and Temozolomide in Ewing's Sarcoma

M.D. Anderson Cancer Center

Phase 1/2 Completed

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡